For nineteen years now the European Conference “Late Breaking Clinical Trials News” for Clinical Research Professionals, has been committed to advancing the knowledge, gain insights and improve the quality of your day to day work in clinical research. It is a must attend conference for anyone interested in clinical trials.
The European Conference is taking place October 27, 2016 in Brussels, Belgium, in the Hilton, and is an event organized by the Belgian Association of Clinical Research Professionals (ACRP.be). Through expert-delivered presentations, you will hear updates on best practices, regulatory developments, industry trends and tips and tools all of which allow you to own your success in clinical research.
Our philosophy in 3 short sentences: For Learning, for Listening and for Life.
So, join us, be a part.
I’m looking forward to seeing you!
The following distinguished speakers will address a presentation at the conference October 2016:
- Diane Kleinermans, advisor for the Minister of public health Maggie De Block opening conference and ‘Belgium as an attractive country for Clinical Trials in the new CT Regulation’
- Yves Geysels, President ACRP.be
- Prof. Bruno Flamion, University of Namur, Real World Late Phase Studies
- Ann Bracke, Legal advisor AZ Groeninge on Legal formalities for the establishment of a database of health information
- Dr Ken Getz, Chairman, CISCRP, US
- Greet Musch, Director General Pre Authorisation, FAGG, on the EU Clinical Trials Regulation
- Dario Pirovano, Regulatory Adviser, Eucomed on Medical Devices
- Gunnar Michielssen on Rehab from E-mail
- Ysbrand Poortman, Member at Scientific Ethics Advisory Group on Patient advocacy groups
- Jonas Renström, Associate Director, Quintiles, and Anca Popa on Risk Based Monitoring, State of art and EU survey
- Panel discussion Risk Based Monitoring pro and contra with Jonas Renström en Vivienne van de Walle
- Harness healthcare data to accelerate clinical studies and enable world-wide collaborative research (speaker TBC)
Tuesday, June 7, 2016 – 16.00 – 18.00
Will Belgium keep it’s pole position after the implementation of the new European Clinical Trials Regulation?
A new European regulation harmonizing the procedures to approve and conduct a clinical trial is coming into force. Through a historical oversight we will define the environment for clinical trials in Belgium, with its strengths and weaknesses, and explains why a competitive environment should be maintained and even strengthened in the challenging and changing European context
Location: SGS Offices, Generaal de Wittelaan 19, 2800 Mechelen, Belgium
Registration: mandatory, provide the relevant details via email to: firstname.lastname@example.org